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Mammalian Cells Cycle without the D-Type
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and Dyson [2002]). The complexity of Rb function is
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phase of the cell cycle. For instance, some of theseF-33076 Bordeaux
targets are additional cyclins, such as the E-type cyclinsFrance
(E1 and E2), whose primary role is to activate Cdk2.
Active E-type cyclin/Cdk2 complexes further phosphor-
ylate pRb (Lundberg and Weinberg, 1998; Harbour etSummary
al., 1999) leading to a wave of transcriptional activity
essential to proceed through the G1/S transition. How-Cdk4 and Cdk6 are thought to be essential for initiation
ever, recent genetic evidence indicating that Cdk2 andof the cell cycle in response to mitogenic stimuli. Previ-
E-type cyclins are not required for mitotic cell divisionous studies have shown that Cdk4 is dispensable for
has challenged this model (Berthet et al., 2003; Ortega etproliferation in most cell types, an observation attrib-
al., 2003; Geng et al., 2003; Parisi et al., 2003). Additionaluted to a putative compensatory role by Cdk6. Cdk6-
work will be necessary to determine the precise role ofnull mice are viable and develop normally although
Cdk2 and E-cyclins as well as the contribution of otherhematopoiesis is slightly impaired. Embryos defective
compensatory kinases before the molecular events thatfor Cdk4 and Cdk6 die during the late stages of embry-
regulate the G1/S transition are fully understood.onic development due to severe anemia. However,
The molecular link between mitogenic signaling andthese embryos display normal organogenesis and
cell cycle progression started to take shape when sev-most cell types proliferate normally. In vitro, embry-
eral groups reported the induction of D-type cyclinsonic fibroblasts lacking Cdk4 and Cdk6 proliferate and
after growth factor signaling or Ras oncogenic activitybecome immortal upon serial passage. Moreover, qui-
(reviewed in Stacey and Kazlauskas [2002]). Moreover,escent Cdk4/Cdk6-null cells respond to serum stimu-
the cyclin D1 promoter contains sequences recognizedlation and enter S phase with normal kinetics although
by several transcription factors such as AP-1 or NF-with lower efficiency. These results indicate that D-type
B, known to be activated upon mitogenic signalingcyclin-dependent kinases are not essential for cell
(reviewed in Amanatullah et al. [2001]). These and other
cycle entry and suggest the existence of alternative
related observations have led to the widely held hypoth-
mechanisms to initiate cell proliferation upon mito-
esis that D-type cyclins, in complex with Cdk4 or Cdk6,
genic stimulation. are the molecular sensors that activate cell cycle pro-
gression in response to mitogenic stimuli (Sherr and
Introduction Roberts, 1999). Likewise, antimitogenic signals, such as
contact inhibition, senescence, or exposure to TGF-,
Progression throughout the mammalian cell cycle is frequently inactivate the formation of D-type cyclin/
driven by heterodimeric kinases made of a regulatory Cdk4 or Cdk6 complexes by inducing expression of a
subunit, designated as cyclin, and a catalytic subunit family of cell cycle inhibitors known as INK4 (Inhibitor
known as cyclin-dependent kinase or Cdk. Two of these of Cdk4). The members of this protein family, p16INK4a,
Cdks, Cdk4 and Cdk6, bind to and are activated by the p15INK4b, p18INK4c, and p19INK4d, are competitive inhibitors
D-type family of cyclins, D1, D2, and D3 (reviewed in of D-type cyclins for binding to Cdk4 and Cdk6 (reviewed
Sherr and Roberts [1999]). In their active form, these in Pavletich [1999]; Sherr and Roberts [1999]).
kinases phosphorylate members of the retinoblastoma The relevance of D-type cyclin/Cdk4 and Cdk6 com-
(Rb) protein family, pRb, p107, and p130. The Rb family plexes in the control of cell proliferation has been under-
of proteins are tumor suppressors that in their active, scored by their frequent deregulation in human cancer.
nonphosphorylated form prevent expression of genes Most, if not all human tumor cells have altered their
necessary for DNA replication (S phase of the cell cycle) D-type cyclin-Cdk4/6-INK4-pRb pathway either by mu-
and mitosis (M phase) (reviewed in Classon and Harlow tations that activate D-type cyclin/Cdk4 or Cdk6 activity
or by mutations that eliminate INK4 or pRb (reviewed in[2002]). In quiescent cells, Rb proteins repress transcrip-
Malumbres and Barbacid [2001]). These observationstion by a complex mechanism that involves inactivation
suggest that mutations that render cells less dependentof transcription factors such as the E2F family and bind-
of growth factor requirements for cell cycle progression
are more likely to become tumorigenic. Likewise, these*Correspondence: malumbres@cnio.es (M.M.), barbacid@cnio.es
mutations presumably make cells less responsive to(M.B.)
antimitogenic signals, one of the hallmarks of cancer3 Present address: Biotechnology Program, CNIO, E-28029 Ma-
drid, Spain. cells (reviewed in Hanahan and Weinberg [2000]).
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Figure 1. Gene Targeting of the Mouse
Cdk6 Locus
(A) Gene targeting strategy. The mouse Cdk6
locus contains seven exons (boxes) spanning
about 260 kbp. Noncoding sequences (open
boxes), coding sequences (filled boxes), and
translational initiator (ATG) and terminator
(TGA) codons are indicated. Sequences pres-
ent in the targeting vector are indicated by a
thick hatched bar. The phosphoglycerol ki-
nase promoter (PGK)-neomycin resistance
gene (neo) cassette is indicated by a gray
box. The arrow indicates the transcriptional
orientation of the cassette. The probe used
to identify the diagnostic PstI (P) fragments
is indicated by a thick bar. Other restriction
sites include BamHI (B), HindIII (H), SAlI (S),
XbaI (X), and SphI (Sp). The position of oligo-
nucleotides used for PCR analysis of the re-
combinant allele are indicated by triangles.
Representative (B) Southern blot and (C) PCR
analysis of recombinant ES cell clones car-
rying the indicated alleles is shown. Migration
of the corresponding DNA fragments is indi-
cated by arrowheads.
However, these observations do not establish whether Results
D-type cyclins and/or their cognate catalytic partners,
Cdk4 and Cdk6, are the only elements that mediate Generation of Cdk6 Knockout Mice
To ablate the functional mouse Cdk6 locus, we replacedthe cell cycle response to mitogenic and antimitogenic
signaling. In an effort to address this question, gene- its first coding exon with a PGK-neo cassette by homolo-
gous recombination in embryonic stem (ES) cells. Thistargeted mice deficient for each, or even two, D-type
cyclins have been generated (Fantl et al., 1995; Sicinski exon encodes the ATG initiation codon and the PLSTIRE
domain essential for cyclin binding (Figure 1). Identifica-et al., 1995, 1996; Ciemerych et al., 2002; Sicinska et
al., 2003). In general, D-type cyclins have overlapping tion of recombinant neoR ES cell clones was determined
by DNA hybridization and PCR amplification (Figuresroles in those tissues where more than one family mem-
ber is expressed. Similarly, mice deficient in Cdk4 (Rane 1A–1C). Two independent ES cell clones carrying the
expected recombination event were aggregated withet al., 1999; Tsutsui et al., 1999) are viable and only
display proliferative defects in specific endocrine cell CD1 morulae or microinjected into C57BL/6J blasto-
cysts to generate Cdk6/ mice. Heterozygous mice de-types (Martı´n et al., 2003; Moons et al., 2002). Whereas
at least some of these defects could be attributed to veloped normally and did not show obvious abnormali-
ties. Matings between these mice yielded homozygousthe absence of Cdk6 expression in the affected cell
types, it is unlikely that the lack of widespread prolifera- Cdk6/ animals at the expected Mendelian ratio (79/
279 [28%] Cdk6/ mice versus 66/279 [24%] Cdk6/tive defects in Cdk4-null animals can be solely explained
by the compensatory activity of Cdk6. animals). Mice lacking Cdk6 did not display gross ana-
tomical abnormalities or increased mortality for up toTo analyze the physiological roles of Cdk4 and Cdk6
in vivo as well as to dissect their specific contributions two years of life. However, mutant females were slightly
smaller than their wild-type littermates (15% lowerto cell cycle progression after mitogenic stimuli, we have
generated mice defective for Cdk6 as well as double weight at 12 weeks of age) and about 30% were sterile,
a defect likely due to a decreased number of maturemutant mice lacking both Cdk4 and Cdk6. Here, we
report that Cdk6-deficient mice are viable and display follicles (about 20%–50% of those present in wild-type
mild defects in defined hematopoietic cell populations. ovaries) (data not shown). Whether these defects, along
Double deficiency in Cdk4 and Cdk6 results in either with the reduced size of Cdk6-null females, are due to
late embryonic or postnatal lethality, most likely due to a hormonal deficiency remains to be determined.
a defect in the erythroid lineage that results in severe
anemia. However, Cdk4- and Cdk6-null embryos display
Defective Hematopoiesis in Cdk6/ Micenormal organogenesis and cell proliferation levels. We
Cdk6 is expressed in most mammalian tissues althoughalso report here that Cdk4 and Cdk6 double mutant
it is most abundant in lymphoid organs (Meyerson etmouse embryonic fibroblasts (MEFs) proliferate in re-
al., 1992; Meyerson and Harlow, 1994). As illustrated insponse to serum stimulation and become immortalized
Figure 2A, Cdk6 was expressed in wild-type but notupon continuous passage. These observations suggest
in Cdk6-null lymphocytes. In Cdk6-deficient mice, thethat D-type cyclin-dependent kinases are not essential
thymus was reduced in size due to lower cellularityfor cell cycle progression of quiescent cells upon expo-
sure to mitogenic stimuli. (0.96 0.3 108 cells in mutant mice versus 1.7 0.4
Cell Proliferation without Cdk4 and Cdk6
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Figure 2. Hematopoietic Defects in Cdk6/
Mice
(A) Immunohistochemical identification of
Cdk6 in thymus from (a and c) wild-type and
(b and d) and Cdk6/ mice. Representative
sections of (e) wild-type and (f) Cdk6/
spleens showing a defect in the red pulp of
Cdk6-null mice. Arrowheads indicate mega-
karyocytes. (a, b, e, and f) 100; (c and d)
630.
(B) Percentage of erythroid cells in the spleen
of (filled column) Cdk6/, (open column)
Cdk6/, and (hatched column) Cdk4n/n mice.
(C) Percentage of (open squares) Cdk6/
and (filled circles) Cdk6/ lymphocytes in S
phase at the indicated times after stimulation
with PMA  Ionomycin.
(D) Expression of cell cycle regulators in lym-
phocytes from Cdk6/ and Cdk6/ mice
stimulated with PMA  Ionomycin. Cell ex-
tracts were analyzed by Western blot at the
indicated times using antibodies against
Cdk4, cyclin D2, cyclin D3, and Erk and
against a phosphorylated serine residue
(Ser780) of pRb.
108 cells in wild-type littermates, [n12]), and its cortical phages, neutrophils, and platelets was also reduced in
the peripheral blood of some, but not all mutant micearea was atrophic in about one third of the mutant ani-
mals (Figures 2Aa and 2Ab). The spleen of Cdk6/ mice (data not shown). The reason for this variability remains
to be determined.was also reduced in size due to decreased cellularity
(1.8  0.4  108 cells in mutant versus 3.0  0.5 cells Cdk6/ mice did not display obvious deficiencies in
the bone marrow. The medullary space of the femurin wild-type spleens, [n  12]). Histological examination
revealed normal white pulp but decreased cell density was filled with densely cellular marrow interspersed with
sinusoidal channels as in control mice. Erythroid, my-in the red pulp (Figures 2Ae and 2Af). Whereas in wild-
type mice 70%–75% of all spleen cells belong to the eloid, and lymphoid lineages were represented without
maturation gap (data not shown). Medullary fat was alsoerythroid lineage, these figures decreased to 35%–40%
in Cdk6/ littermates (Figure 2B). Similarly, the number present in the bone marrow of Cdk6/ mice. These
observations suggest that Cdk6 is required for expan-of megakaryocytes was severely reduced to less than
one third of those present in wild-type spleens (Figures sion of certain differentiated compartments rather than
for proliferation of early hematopoietic precursors.2Ae and 2Af).
Red cells in peripheral blood were also decreased in
Cdk6-null mice by about 15%. This reduction, however, Delayed S Phase Entry in Cdk6/ Lymphocytes
No significant deficiencies were observed in the numberdid not have major physiological consequences since
Cdk6/ mice had basically normal levels of hemoglobin of peripheral lymphocytes in Cdk6/ mice. Moreover,
B cells and T cells were present at the expected ratiosin their blood. This compensatory effect is due to an
increase in the volume of Cdk6/ erythrocytes and a (data not shown). Within thymic T cells, however, there
was a slight but consistent increase of CD4 (from 24.5%higher concentration of hemoglobin within red cells
(data not shown). The number of granulocytes, macro- to 30.6%) and CD8 (from 7.4% to 13.2%) single positive
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populations and a consequent decrease of immature
double positive cells (from 67.8% to 56.0%). Since Cdk6
is thought to play a key role in the proliferative response
of T cells upon mitogenic stimulation, we treated T cells
from Cdk6/ mice and control littermates with PMA
and ionomycin. Under these conditions, wild-type lym-
phocytes reached a peak of DNA synthesis in 36–40 hr
after mitogenic stimulation. In contrast, the percentage
of Cdk6/ lymphocytes in S phase reached maximum
levels at 54 hr after treatment (Figure 2C). Similar results
were obtained after stimulation with anti-CD3, conca-
navalin A, or PHA (data not shown). Induction of cyclin
D3 expression and, to a lesser extent, cyclin D2 expres-
sion were also found to be delayed (Figure 2D). Finally,
pRb phosphorylation, a marker of Cdk6 kinase activity,
was delayed 10 to 14 hr, at least as determined by
phosphorylation of Ser780, a residue thought to be spe-
cific for D-type cyclin-dependent Cdks (Figure 2D).
These observations provide genetic evidence for the
concept that Cdk6 is a regulator of the proliferative re-
sponse of T lymphocytes upon mitogenic stimuli. More-
over, they illustrate the existence of functional, albeit
less efficient compensatory mechanisms that allow pro-
liferation of resting T lymphocytes in the absence of
Cdk6.
Unlike Cdk6/ lymphocytes, primary (P2) Cdk6-null
MEFs grew well in culture and did not display significant
proliferative defects (not shown). In addition, serum-
starved P2 Cdk6/ MEFs entered S phase with normal
kinetics upon serum stimulation. Finally, Cdk6/ MEFs
underwent cell culture crisis after a few passages and
became immortal upon continuous passage with effi-
ciencies similar to those of wild-type MEFs.
Absence of Synergism between Cdk6
and Cdk2 Deficiencies
Next, we investigated whether concomitant loss of Cdk6
Figure 3. Characterization of Cdk4 and Cdk6 Double Mutant Em-and Cdk2 may have synergistic effects. Double Cdk6/;
bryosCdk2/ heterozygous mice developed normally. More-
E16.5 embryos deficient in (A, C, E, G, and I) Cdk6 or (B, D, F, H,over, crosses between these mice yielded all possible
and J) both Cdk4 and Cdk6 display normal organogenesis and cell
genotypes at the expected Mendelian ratios. Mice de- proliferation in most tissues. (A and B) Wholemount preparation
fective for Cdk6 and Cdk2 display those phenotypical under the binocular microscope; (C and D) Hematoxilin and eosyn
abnormalities previously observed in Cdk2 and Cdk6 staining of a sagital section of the above embryos (16); BrdU
incorporation in (E and F) the skin and whisker follicles (100) andsingle mutants (Ortega et al., 2003; this study). Briefly,
(G and H) in the intestine (400); and (I and J) TUNEL assay in theCdk6/;Cdk2/ animals are sterile and show marked
pancreas (100).defects in spermatogenesis and oogenesis, basically
indistinguishable to those reported for Cdk2-deficient
mice (Ortega et al., 2003). They have limited defects in normally and were indistinguishable from wild-type lit-
hematopoietic cells similar to those described above for termates. Crosses between these mice yielded the ex-
Cdk6-null mice. Cdk2 and Cdk6 double mutant animals pected ratio of double heterozygous and Cdk4/n;Cdk6/
have reduced weight due to a decrease in size similar to animals. However, Cdk4n/n;Cdk6/ mice were born at
that observed in Cdk6 and Cdk2 single mutants. Finally, about one forth the expected ratio and, so far, we have
Cdk6/;Cdk2/ animals survive for up to 1.5 years not obtained any live Cdk4n/n;Cdk6/ pups.
without developing any obvious additional abnormal- To determine the reasons for the lack of viability of
ities. Cdk4n/n;Cdk6/ double knockout mice, embryos de-
rived from crosses between Cdk4/n;Cdk6/ mice were
collected at various stages of development, ranging
Late Embryonic Lethality of Cdk4;Cdk6 from embryonic stages 10.5 to 18.5 (E10.5 to E18.5).
Double Mutant Mice E10.5–E12.5 Cdk4n/n;Cdk6/ embryos were generated
To obtain mice without functional cyclin D-dependent at the expected Mendelian ratio. The number of E14.5–
kinases, we crossed Cdk6/ mice with animals hetero- E18.5 embryos was also normal. However, a significant
zygous for a Cdk4-null allele, Cdk4/n (Rane et al., 1999). percentage of them were found dead whereas all
Cdk4/;Cdk6/ embryos were alive. The percentageDouble heterozygous Cdk4/n;Cdk6/ mice developed
Cell Proliferation without Cdk4 and Cdk6
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Figure 4. Defective Hematopoiesis in Cdk4n/n;Cdk6/ Double Mutant Embryos
(A) E16.5 (a, c, e, g, and i) Cdk4/;Cdk6/ and (b, d, f, h, and j) Cdk4n/n;Cdk6/ embryos. Liver sections stained with H&E (a and b) 50; (c
and d) 200. (e and f) Ki67 staining of erythroblasts (1000); (g and h) blood cells stained with H&E (1000) showing occasional apoptosis
in Cdk4n/n;Cdk6/ erythroblasts (arrowheads).
(B) Relative levels of red blood cells in E16.5 embryos of the indicated genotypes. Representative Wright-Giemsa staining of peripheral blood
smears is also shown (1000).
(C) Staining for hematopoietic stem cells (HSC), common lymphoid progenitors (CLP), common myeloid progenitors (CMP), granulocyte-
macrophage progenitors (GMP), and megakaryocyte-erythroid progenitors (MEP) in fetal liver. The relative percentage of selected cell popula-
tions in (top) Cdk4/;Cdk6/ and (bottom) Cdk4n/n;Cdk6/ embryos is shown.
of dead embryos increased with developmental stage. However, all of them were dead when observed a few
hours after delivery.Whereas at E14.5, only 25% of the Cdk4n/n;Cdk6/ em-
bryos were found dead, this percentage increased to Histological examination of these double null embryos
and their corresponding placentas revealed that they50% at E18.5. A few Cdk4n/n;Cdk6/ pups were born.
Cell
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Figure 5. Cell Proliferation in MEFs Lacking
Cdk4 and Cdk6
(A) Proliferation of early passage (P2–P5)
MEFs derived from (open squares) Cdk4/;
Cdk6/; (open circles) Cdk4/;Cdk6/; (gray
circles) Cdk4n/n;Cdk6/; and (filled circles)
Cdk4n/n;Cdk6/ embryos.
(B) Percentage of (filled columns) Cdk4/;
Cdk6/ and (open columns) Cdk4n/n;Cdk6/
MEFs in S phase at the indicated passages
(P1 to P5).
(C) Percentage of quiescent MEFs in S phase
at the indicated times after serum stimulation.
Symbols are those described in (A).
(D) Levels of cyclin D1, phosphorylated and
unphosphorylated pRb, cyclin E, cyclin A, and
-actin proteins at the indicated times after
serum stimulation of quiescent MEFs derived
from Cdk4/;Cdk6/ or Cdk4n/n;Cdk6/ em-
bryos.
were well formed and did not present significant abnor- number of red blood cells (Figure 4B). Moreover, these
cells depicted a megaloblastic feature typically seen inmalities, except for a consistent reduction in size (about
15% to 20%; Figures 3A–3D). All tissues examined dis- anemia caused by impaired division of erythroid precur-
sors (Figure 4B). These findings suggest that Cdk4n/n;played normal levels of Ki67-positive cells (not shown)
and BrdU incorporation (Figures 3E–3H). Similarly, these Cdk6/ embryos die during the late stages of embry-
onic development due to limited proliferation of ery-double knockout embryos had normal levels of apo-
ptotic cells in all tissues examined (Figures 3I and 3J). throid progenitors. Interestingly, this phenotype is highly
reminiscent of the profound anemia described in em-However, starting at developmental stage E14.5, we
consistently observed a percentage of dead embryos. bryos deficient for cyclin D2 and cyclin D3, the two
D-type cyclins known to be expressed in hematopoieticE14.5 to E18.5 Cdk4n/n;Cdk6/ embryos had structurally
aberrant livers that contained decreased levels (40 to cells (Ciemerych et al., 2002).
To understand the origin of these hematopoietic ab-60%) of Ter119 erythroid precursors (Figures 4Aa–
4Ad). This atrophy was associated with dilated and less normalities, we analyzed different hematopoietic stem
cells (HSC) and progenitors in fetal livers. By E15.5,populated blood vessels. Moreover, less than 2% of
these mutant erythroid progenitor cells (erythroblasts) Cdk4n/n;Cdk6/ livers display a significant reduction in
cellularity (7.1  106 cells versus 20–22  106 cells inwere in a proliferative stage whereas in wild-type or
single mutant embryos, 20%–50% of their erythroblasts Cdk4/;Cdk6/ and wild-type livers). The relative lev-
els of double mutant HSCs were not reduced althoughdisplayed mitotic figures and were positive for Ki67 (Fig-
ures 4Ae and 4Af). We also observed occasional apo- their absolute numbers were decreased due to the lower
cellularity of the mutant livers (Figure 4C). However, theptotic figures in erythroblasts of Cdk4n/n;Cdk6/ mice
but not in littermates with other genotypes (Figures 4Ag levels of other Cdk4/6-null lineage-committed progeni-
tors, such as common lymphoid progenitors (CLP), com-and 4Ah).
Analysis of peripheral blood in E16.5–E18.5 Cdk4n/n; mon myeloid progenitors (CMP), and granulocyte-mac-
rophage progenitors (GMP), were reduced beyond thoseCdk6/ embryos revealed a dramatic decrease in the
Cell Proliferation without Cdk4 and Cdk6
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Figure 6. D-Type Cyclin/Cdk Complexes in
MEFs Lacking Cdk4 and Cdk6
(A) Identification of cyclin D1/Cdk2 com-
plexes in MEFs derived from embryos with
the indicated genotypes. The migration of
cyclin D1 and Cdk2 is indicated by arrow-
heads. One tenth of the total cell extract used
for immunoprecipitation was loaded as a con-
trol. Another control using an unrelated anti-
body for immunoprecipitation is also in-
cluded (mock).
(B) In vitro kinase activity of cyclin D2/Cdk2
immunoprecipitates obtained from Cdk4/;
Cdk6/, Cdk4/;Cdk6/, and Cdk4n/n;
Cdk6/ MEFs using a fragment of pRb and
histone H1 as substrates. Kinase activity of
immunoprecipitates obtained from wild-type
MEFs with antisera raised against Cdk2 and
Cdk4 are included as controls.
(C) In vitro kinase activity in cyclin D2 immu-
noprecipitates from MEFs derived from
Cdk4/;Cdk6/ and Cdk4n/n;Cdk6/ em-
bryos after immunodepletion of Cdk2 with
anti-Cdk2 antibodies. IP, immunoprecipita-
tion; WB, Western blot; Depl., immunodeple-
tion. Mock indicates immunoprecipitation
with an unrelated antibody.
levels expected from the decreased cellularity (Figure Cdk4n/n;Cdk6/ MEFs required a considerably longer
time for cell doubling (72 versus 52 hr). Moreover, the4C). Indeed, the absolute numbers of double mutant
percentage of Cdk4n/n;Cdk6/ MEFs progressing throughCLPs, CMPs, and GMPs were around 15% of those of
S phase dropped from 28% at P2 to 14% at P4, a dropcontrol livers. Accordingly, the numbers of more mature
not observed in wild-type MEFs (39% versus 36%) (Fig-hematopoietic cells such as monocytes, macrophages,
ure 5B). Finally, at P4–P5, a time when control cells wereor lymphocytes were also reduced (data not shown).
still proliferating actively, double mutant MEFs begin toSurprisingly, the reduction of double mutant megakaryo-
display features of senescent cells. Yet, all Cdk4n/n;cyte-erythroid progenitors (MEP) was less severe (about
Cdk6/ MEFs became immortalized upon continuous40% of controls). Whether this is due to a feedback
passage in culture following a classical 3T3 protocol.mechanism that favors the formation of these intermedi-
For reasons unknown to us, the timing at which theseate precursors in an attempt to compensate for the ane-
cultures became immortal varied significantly from em-mia observed in these double mutant embryos remains
bryo to embryo. In addition, Cdk4n/n;Cdk6/ MEFs wereto be determined. Finally, a dramatic defect in the prolif-
also able to proliferate in low serum conditions (2%–5%erative potential of all these precursors was observed
fetal calf serum) and respond to mitogenic stimuli in-using fetal liver cell preparations for functional col-
duced by addition of EGF and IGF-1. However, the rateony formation assays in methylcellulose. The number
of proliferation was consistently lower than that ob-of colony-forming units for granulocytes, macrophages,
served in control cultures (data not shown). These ob-mixed granulocytes/macrophages, and mixed granulo-
servations, taken together, indicate that D-type cyclin-cytes/macrophages/erythrocytes/megakaryocytes was
dependent kinases are required but not essential forseverely reduced in Cdk4n/n;Cdk6/ livers (less than 5%
proliferation of embryonic fibroblasts.of controls), whereas the number of erythroid burst-
Since Cdk4 and Cdk6 complexes have been proposedforming units was about 10% of control livers.
to be the major sensors for integrating mitogenic signal-
ing during exit from quiescence, we analyzed the re-
MEFs Cycle and Exit Quiescence sponse of quiescent Cdk4n/n;Cdk6/ MEFs to serum
without Cdk4 and Cdk6 stimulation. As illustrated in Figure 5C, serum-starved
Early passage Cdk4n/n;Cdk6/ MEFs proliferate well al- P2 Cdk4n/n;Cdk6/ MEFs enter S phase with kinetics
beit at a slower rate than control cells (Figure 5A). similar to those of wild-type MEFs. However, the per-
Whereas the doubling time of P2 double mutant MEFs centage of cells progressing through the S phase at a
given time was only half of that in normal MEFs (Figurewas similar to that of wild-type MEFs (about 28 hr), P4
Cell
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Figure 7. Cell Cycle Arrest by Cdk2 Interfer-
ence or Cell Cycle Inhibitors in Cdk4/Cdk6-
Deficient MEFs
(A) Empty retroviruses () or retroviruses ex-
pressing a shRNA against Cdk2 () were
used to infect wild-type or two independent
Cdk4 and Cdk6 double mutant MEFs. The
migration of the long and short forms of Cdk2
is indicated by arrowheads.
(B) BrdU incorporation in wild-type or Cdk4
and Cdk6 double mutant MEFs infected with
(filled columns) empty () or (open columns)
Cdk2 shRNA () retroviruses.
(C) Levels of expression of p16INK4a, p21Cip1,
and p27Kip1 cell cycle inhibitors in Cdk4/;
Cdk6/ and Cdk4n/n;Cdk6/ MEFs. The lev-
els of p21Cip1 and p27Kip1 complexed with Cdk2
were also determined by immunoprecipita-
tion of Cdk2 with specific antibodies. The mi-
gration of these inhibitors and control actin
protein is indicated by arrowheads.
(D) Relative levels of BrdU incorporation in
MEFs with the indicated genotypes after in-
fection with retroviruses encoding (gray col-
umns) p16INK4a or (open columns) p21Cip1 inhib-
itors with respect to MEFs infected with (filled
columns) the retroviral vector alone.
5C). Moreover, primary Cdk4n/n;Cdk6/ MEFs displayed (Figure 6B). In Cdk4n/n;Cdk6/mutant MEFs, pRb kinase
activity by cyclin D immunoprecipitates is at least par-a delay in overall pRb phosphorylation (Figure 5D) as
well as in phosphorylation of specific residues such as tially due to Cdk2 since immunodepletion with Cdk2
antibodies decreased the levels of pRb phoshorylationSer780 and Ser807/811 (not shown). In agreement with
these observations, expression of cyclin E and cyclin A (Figure 6C).
To further analyze the possible role of Cdk2 in thewas concomitantly delayed (about 4 hr) in these double
mutant MEFs (Figure 5D). proliferation of Cdk4n/n;Cdk6/ MEFs, we infected wild-
type and double mutant cells with retroviruses encodingAblation of Cdk4 and Cdk6 does not affect the expres-
sion of D-type cyclins (Figure 5D). Therefore, we exam- a shRNA against Cdk2. These viruses reduced the
amount of Cdk2 protein by 70%–90% (Figure 7A). Asined whether these cyclins could be bound to other
partners in the absence of their cognate kinases. Indeed, illustrated in Figure 7B, Cdk2 shRNA did not affect prolif-
eration of wild-type cells but produced a significant de-previous studies have shown that a fraction of cyclin
D1 is bound to Cdk2, at least in certain cells (Matsushime crease in the rate of BrdU incorporation in Cdk4n/n;
Cdk6/ MEFs. These observations suggest that in theet al., 1992; Xiong et al., 1992; Lukas et al., 1995). As
illustrated in Figure 6A, D-type cyclins can complex with absence of Cdk4 and Cdk6, Cdk2 associates with
D-type cyclins inducing pRb phosphorylation and cellCdk2 in wild-type MEFs. These complexes appear to
be more abundant in Cdk4n/n;Cdk6/ mutant MEFs. To proliferation.
We have also examined the levels of Cdk inhibitorsanalyze whether these D-type cyclin/Cdk2 complexes
had kinase activity, we immunoprecipitated protein ly- in cells lacking Cdk4 and Cdk6. As shown in Figure 7C,
Cdk4n/n;Cdk6/ MEFs have reduced levels of p16INK4a,sates derived from double mutant MEFs with anti-cyclin
D2 antibodies (Figure 6B). These immunoprecipitates p21Cip1, and p27Kip1 inhibitors. These observations could
be due to decreased protein stability or to a feedbackphosphorylated pRb but not histone H1, a phosphoryla-
tion pattern characteristic of D-type cyclin/Cdk4 and mechanism that reduces the overall levels of cell cycle
inhibitors in the absence of Cdk4 and Cdk6. To distin-Cdk6 complexes. As expected, control Cdk2 immuno-
precipitates phosphorylated both pRb and histone H1 guish between these two possibilities, we analyzed the
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levels of p21Cip1 and p27Kip1 bound to Cdk2. As illustrated onic development and display normal cell proliferation
and apoptosis in most cell types. Instead, the main de-in Figure 7C, Cdk2 immunoprecipitates contained the
fects observed in these double mutant embryos are lim-same levels of these inhibitors as in control MEFs, sug-
ited to the compromised maturation of different hemato-gesting that the differences observed in their overall
poietic lineages and severely reduced numbers (aboutlevels are due to the fraction bound to Cdk4 and Cdk6,
15% of normal levels) of circulating red blood cells.which is missing in these double mutant cells.
These defects, which lead to severe anemic conditions,Finally, we investigated whether Cdk4n/n;Cdk6/ cells
are most likely to be responsible for the death of thesewere still sensitive to the inhibitory properties of p16INK4a
double mutant embryos. These observations, taken to-and p21Cip1. To this end, we infected wild-type, Cdk4n/n;
gether, indicate that D-type cyclin-dependent kinasesCdk6/, Cdk4/;Cdk6/, and Cdk4n/n;Cdk6/ mutant
are not essential for proliferation of most cell types, atMEFs with retroviruses encoding either p16INK4a or
least during embryonic development. Since these pro-p21Cip1. Whereas p16INK4a strongly inhibited DNA replica-
teins are thought to play a key role in bringing quiescenttion (measured as BrdU incorporation) in 60%–80% of
cells back to the cycle upon mitogenic stimuli, it couldwild-type and single mutant MEFs, it failed to block
be argued that during embryonic development, cells docell cycle progression in Cdk4n/n;Cdk6/ double mutant
not withdraw from the cycle or, if they do, they withdrawcells (Figure 7D). In contrast, p21Cip1 was able to block
to a resting state fundamentally distinct from the quies-BrdU incorporation in all cells. These observations pro-
cence state characteristic of nonproliferating adult cells.vide genetic evidence for the specificity of p16INK4a in
These arguments, however, cannot be substantiatedthe inhibition of D-type cyclin-dependent kinases, Cdk4
by in vitro studies. Cdk4- and Cdk6-deficient MEFs pro-and Cdk6.
liferate well, undergo senescence, and become immor-
tal upon continuous passage in a fashion very similar toDiscussion
wild-type MEFs. More importantly, these mutant MEFs
become quiescent upon serum withdrawal and re-enterCdk4 and Cdk6 are closely related proteins with basi-
the cycle upon mitogenic stimulation with normal kinet-cally indistinguishable biochemical properties. Thus, the
ics. Interestingly, these cells display reduced levels ofspecific roles of these catalytic subunits are most likely
pRb phosphorylation and delayed expression of cyclinsdetermined by their differential patterns of expression.
E and A, the activating partners of Cdk2. These observa-Since Cdk6 is preferentially expressed in hematopoietic
tions argue against the commonly accepted hypothesiscells, it has been proposed as the kinase that initiates
that couples activation of Cdk2 with the start of DNApRB phosphorylation in T lymphocytes (Meyerson and
synthesis. Moreover, they also challenge the widely heldHarlow, 1994). Likewise, the differential expression of
concept that full pRb phosphorylation by both Cdk4/6Cdk4 and Cdk6 has led to the proposal that they regulate
and Cdk2 kinases is required for proper G1/S transitioncell division at different stages of erythroid maturation
(Lundberg and Weinberg, 1998; Harbour et al., 1999).(Matushansky et al., 2000). In MEL erythroleukemia
Additional studies involving a more detailed character-cells—transformed erythroid precursor cells blocked at
ization of pRb and other transcriptional regulators in
the proerythroblast stage—differentiation requires inhi-
these Cdk4/Cdk6 double mutant MEFs will be required
bition of Cdk6 but not of Cdk4 (Matushansky et al.,
to understand the precise role of D-type cyclin/Cdk
2000). Accordingly, erythropoietin-dependent terminal
complexes in cell cycle progression.
differentiation of primary erythroblasts correlates with Our results establish that D-type-dependent Cdk4 and
an early decline of Cdk6 activity followed by a later Cdk6 are not essential for exit from quiescence or for cell
decline in Cdk4 activity (reviewed in Steinman [2002]). cycle progression. Yet, the percentage of MEFs lacking
Our observations indicating that loss of Cdk6 primarily Cdk4 and Cdk6 that re-enter the cycle at a given time
affects the hematopoietic system are, for the most part, upon serum stimulation is about half of those expressing
in agreement with these observations. For instance, loss one or both Cdks. Thus, whatever mechanisms may be
of Cdk6 leads to delayed G1 progression in lymphocytes responsible for compensating the lack of these Cdks
but not in MEFs. In vivo, Cdk6 deficiency results in lower are not as efficient in rescuing cells from quiescence.
cellularity in hematopoietic tissues such as thymus and A molecule possibly responsible for this compensatory
spleen. Peripheral blood of Cdk6-deficient mice also activity is Cdk2. In agreement with previous reports
had reduced numbers of red blood cells. These observa- (Matsushime et al., 1992; Xiong et al., 1992; Meyerson
tions suggest that Cdk6 is required for expansion of and Harlow, 1994; Lukas et al., 1995; Sweeney et al.,
differentiated populations rather than for proliferation of 1997), we have observed the association of Cdk2 with
early hematopoietic precursors. Whereas these obser- D-type cyclins. These complexes are more abundant in
vations underscore the need of Cdk6 for proper hemato- the absence of Cdk4 and Cdk6 and, more importantly,
poietic homeostasis, they also indicate that Cdk6 is not have pRb kinase activity. The specificity of this kinase
essential for proliferation of any specific cell lineage. corresponds to that of D-type cyclin/Cdk4 or Cdk6
Previous genetic studies in C. elegans and D. melano- rather than to E-type cyclin/Cdk2 complexes, an obser-
gaster cyclin D-Cdk4 homologs have shown that these vation consistent with the concept that substrate speci-
proteins are primarily involved in the regulation of post- ficity of Cdks is primarily determined by their partner
embryonic growth in specific cell types since ablation of cyclins (Pavletich, 1999). Moreover shRNA specific for
the corresponding genes is compatible with embryonic Cdk2 inhibits proliferation of double mutant but not wild-
development (Park and Krause, 1999; Meyer et al., 2000). type MEFs. These results implicate Cdk2 in the prolifera-
In contrast, mice lacking Cdk4 and Cdk6 are not viable. tion of Cdk4- and Cdk6-deficient cells. However, our
observations do not prove that Cdk2 fully compensatesYet, these embryos die during the late stages of embry-
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linearized and electroporated into mouse R1 ES cells, and recombi-the lack of these Cdks since other kinases might be
nant clones were selected in the presence of G418 and gancyclovir.present in cyclin D immunoprecipitates. Likewise, the
Seven G418R/GanR clones were identified by Southern hybridizationused Cdk2 shRNA may also affect expression of other
using probes external to the targeting vector (Figure 1). Since the
related proteins. In an attempt to resolve this issue, mouse genome contains several Cdk6 genomic pseudogenes (data
we have undertaken the task of generating triple Cdk4, not shown), those recombinant clones (ESMM1-76 and ESMM1-
332) used to generate chimeric mice were further characterized byCdk6, Cdk2 knockout mice. Unfortunately, loci encoding
sequencing of adjacent regions after long-template PCR amplifica-Cdk4 and Cdk2 map too closely within the mouse ge-
tion. These clones were aggregated to CD1 or microinjected intonome to allow in vivo recombination at acceptable fre-
C57BL/6J blastocysts to generate chimeras. No significant differ-quency. Thus, generation of triple recombinant mice
ences have been observed between mice derived from these inde-
requires targeting the Cdk4 locus within a Cdk2-null pendent clones in 129  CD1 or 129  C57BL6/J genetic back-
background. grounds. These heterozygous mice were intercrossed to generate
mouse colonies in the 129  CD1 background or backcrossed toRegardless of the outcome of these results, it is un-
generate a pure C57BL/6J colony. Most of the experiments de-likely that Cdk2 is sufficient to compensate for the ab-
scribed in this manuscript were carried out with animals in the 129sence of Cdk4 and Cdk6, at least by a mechanism involv-
CD1 background. Mice were maintained according to the animaling interaction with D-type cyclins. In an accompanying
care standards established by the Europan Union. Genotyping of
manuscript, Sicinski and coworkers (Kozar et al., 2004 Cdk6-null mice was carried out by PCR amplification using specific
[this issue of Cell]) report that MEFs lacking the three oligonucleotides for the normal or mutant allele (primer sequences
are available from the authors upon request). Cdk4 and Cdk2 mutantD-type cyclins grow well in culture and can be rescued
mice were genotyped as previously described (Rane et al., 1999;from quiescence by mitogenic stimulation with kinetics
Ortega et al., 2003).similar to those observed in Cdk4/Cdk6-deficient MEFs.
Thus, it is unlikely that whatever mechanisms are re-
Histopathologic Analysessponsible for compensating the lack of Cdk4 and Cdk6
Embryos or organs dissected from mice were fixed in 10%-buffered
involve D-type cyclins. However, D-type cyclins defi- formalin (Sigma) and embedded in paraffin. Three or five microme-
cient mice die a couple of days earlier than those lack- ter-thick sections were stained with hematoxylin and eosin. Periph-
ing their cognate Cdk4 and Cdk6 catalytic subunits. eral blood was obtained from the eye of 2- to 4-month-old mice or
from carotid arteries of embryos. Blood smears were prepared usingWhereas these subtle differences might be due, at least
the wedge technique, followed by air-drying and Wright-Giemsain part, to different genetic backgrounds, it is also possi-
staining. Blood populations were quantified using a blood analyzerble that the limited kinase activity provided by D-type
(Diatron Messtechnik, Wien) and a flow cytometer (see below).
cyclin/Cdk2 complexes in Cdk4/Cdk6-null cells may ac-
count for the longer life span of the Cdk4/Cdk6 double Immunohistochemistry and Cytometry
mutant embryos. For proliferation studies, tissues or embryos were stained with Ki67-
It has recently been reported that Cdk3/cyclin C com- specific antibodies (Dako) or labeled with BrdU (Sigma). Pregnant
females were injected intraperitoneally with BrdU at 100 g/g ofplexes promote G0/G1 transition in a pRb-dependent
body weight and embryos and placentas were collected after 2 hrmanner in several different human cell lines (Ren and
and fixed in formalin. Paraffin sections were stained with anti-BrdURollins, 2004). This kinase, however, is not active in
antibody (Becton Dickinson), followed by detection with the Vecta-
most laboratory mouse strains (Ye et al., 2001), including stain ABC kit (Vector Laboratories). Detection of apoptotic cells on
those used in this study (our unpublished observations). tissue sections was carried out using the TUNEL assay (Apoptag
Therefore, Cdk3 cannot contribute to the observed lev- Peroxidase, Intergen). Cell surface markers used to identify the spe-
cific hematopoietic populations in thymus, spleen, bone marrow, orels of cell proliferation in the absence of Cdk4 and Cdk6.
peripheral blood include CD3, CD4, CD8, CD11B, CD25, CD34,Whether loss of these kinases in a strain that carries a
CD44, CD69, IL-7, IgM, GR1, Ter119, B220, and F4/80 (Pharmingen).functional Cdk3 may display a less severe phenotype
The hematopoietic progenitors in fetal liver were stained as pre-
remains to be determined. viously described (Akashi et al., 2000; Traver et al., 2001). HSCs
Taken together, our studies, along with those of Kozar were identified as Lin IL7R	 c-Kit Sca1; CLPs as Lin IL7R	
et al. (2004), challenge the concept that D-type cyclin/ c-Kitlow Sca1low; CMPs as Lin IL7R	 c-Kit Sca1 Fc
Rlow CD34;
GMPs as Lin IL7R	 c-Kit Sca1 Fc
Rhi CD34; and MEPs asCdk4 and Cdk6 complexes are the only sensors of mito-
Lin IL7R	 c-Kit Sca1 Fc
Rlow CD34. Their relative numbersgenic signaling to rescue cells from quiescence. These
were quantified by using Coulter (XL) or BD Biosciences cytometers.findings are reminiscent of recent observations that
Cdk2 (Ortega et al., 2003; Berthet et al., 2003) and E-type
Cell Culture Assayscyclins (Geng et al., 2003; Parisi et al., 2003) are also
Mouse embryonic fibroblasts (MEFs) were isolated from E13.5 em-
dispensable for mitotic cell division. Conditional Cdk4/ bryos and cultured in Dulbecco’s modified Eagle’s medium (DMEM)
Cdk6 double mutant mice or triple cyclin D mutant ani- supplemented with 2 mM glutamine, 1% penicillin/streptomycin,
and 10% fetal bovine serum (FBS) or 10% calf serum (CS). MEFsmals will provide additional tools to dissect the role
were maintained in culture using a standard 3T3 protocol. Prolifera-of D-type cyclin/Cdk kinases in mammalian postnatal
tion and immortalization assays were performed as previously de-development and adult homeostasis.
scribed (Sotillo et al., 2001). To analyze S phase entry, passage 2
MEFs (106 cells per 10 cm dish) were deprived of serum for 48 hr
in DMEM  0.1% FBS and restimulated with 10% FBS to enterExperimental Procedures
the cell cycle. DNA content was analyzed by flow cytometry after
propidium iodide staining (Coulter XL or FACScan from Becton-Gene Targeting of Cdk6
Mouse Cdk6 cDNAs and genomic sequences were cloned by plate Dickison). Retroviral infection of primary MEFs was performed using
pBabe-puro-p16INK4a, pBabe-puro-p21Cip1, or the empty vector. Afterhybridizations from a mouse testis cDNA library and a lambda geno-
mic library, respectively. For excision of the first exon of Cdk6, which infections, cells were selected in puromycin for 2 days and stained
for BrdU incorporation after 12 hr in the presence of 50 M BrdU.contains the PLSTIRE sequences, we subcloned upstream and
downstream genomic fragments in the pPNT vector (Tybulewicz et For Cdk2 knockdown experiments, primary MEFs were infected
with Cdk2-C, a retroviral construct expressing a shRNA against theal., 1991) (Figure 1). The resulting targeting vector, pMM450, was
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murine Cdk2 (a gift of P. Sicinski). Primary lymphocytes were iso- Harbour, J.W., and Dean, D.C. (2000). The Rb/E2F pathway: ex-
panding roles and emerging paradigms. Genes Dev. 14, 2393–2409.lated from spleen or thymus of 3-month-old mice and cultured in
RPMI  10% FBS. For proliferation studies, T cells were stimulated Harbour, J.W., Luo, R.X., Dei Santi, A., Postigo, A.A., and Dean,
with PMA and ionomycin, concanavalin A or PHA (Sigma), or anti- D.C. (1999). Cdk phosphorylation triggers sequential intramolecular
CD3 (Pharmingen), and cell cycle profiles analyzed by cytometry. interactions that progressively block Rb functions as cells move
For hematopoietic colony formation assays, fetal livers were col- through G1. Cell 98, 859–869.
lected from E15.5 embryos, and 2–6  104 cells were plated in
Kozar, K., Ciemerych, M.A., Rebel, V.I., Shigematsu, H., Zagozdzon,
duplicates in methylcellulose supplemented with stem cell factor,
A., Sicinska, E., Geng, Y., Yu, Q., and Bhattacharya, S., Bronson,
interleukin (IL)3, IL6, and erythropoietin (Stem Cell Technologies).
R.T., Akashi, K., and Sicinski, P. (2004). Mouse development and
Colonies were scored at day 12 as indicated by the manufacturer.
cell proliferation in the absence of D-cyclins. Cell 118, this issue,
477–491.
Protein Analysis Lukas, J., Bartkova, J., Welcker, M., Petersen, O.W., Peters, G.,
Protein lysates were isolated and used for protein analysis by immu- Strauss, M., and Bartek, J. (1995). Cyclin D2 is a moderately oscillat-
noblotting as previously described (Sotillo et al., 2001). Antibodies ing nucleoprotein required for G1 phase progression in specific cell
against the following proteins were used: Cdk2, Cdk1, Cdk4, cyclin types. Oncogene 10, 2125–2134.
A, cyclin E, cyclin D2, p16INK4a, p21Cip1, Erk (all from Santa Cruz Bio-
Lundberg, A.S., and Weinberg, R.A. (1998). Functional inactivationtechnology), cyclin D1, (Neo Markers), p27Kip1 (Transduction Labora-
of the retinoblastoma protein requires sequential modification by attories), -actin (Sigma), P-Rb-S780, P-Rb-S795 and P-Rb807/811
least two distinct cyclin-cdk complexes. Mol. Cell. Biol. 18, 753–761.(Cell Signaling), and P-Rb-T821 (Biosource International). For kinase
Malumbres, M., and Barbacid, M. (2001). To cycle or not to cycle:assays, 1 g of mouse pRb protein fragment (amino acids 769–921;
a critical decision in cancer. Nat. Rev. Cancer 1, 222–231.Santa Cruz Biotechnology) and histone H1 from calf thymus (Roche
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